Back

Ophthalmic complications in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Treatment of atrial fibrillation and stroke prevention Oral Anticoagulation EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Olivia Costa

University of Connecticut, Storrs (United States of America)

6 More presentations in this session

Presentation thumbnail
Incidence and location of residual gaps identified by a high-density grid-style catheter after PVI is confirmed by pacing the ablation lines
Doctor S. Sundaram (Littleton, US)
Abstract Slides Video
Presentation thumbnail
Catheter ablation outscores all other treatment modalities in reducing all-cause mortality and heart failure related morbidity in patients of persistent atrial fibrillation with systolic heart failure
Doctor D. Khanra (CHESTER, GB)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of a high power short duration ablation-index guided protocol for pulmonary vein isolation using a single catheter
Doctor P. Badertscher (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Shorter interlesion distance is associated with a longer procedure time but not with poorer acute results of pulmonary vein isolation: results from a prospective ablation index registry
Doctor N. Gasimova (Saint Petersburg, RU)
Abstract Slides Video
Presentation thumbnail
Is the optimal blanking period duration after cryoballoon pulmonary vein isolation impacted by use of antiarrhythmic drugs?
Doctor D. Musat (Paramus, US)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of atrial fibrillation and stroke prevention

The Event

Event poster

EHRA 2021

23 April - 25 April 2021
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources